The Horseracing Integrity and Safety Authority has approved funding for three studies that will examine the use of furosemide, the diuretic that is used to mitigate bleeding in the lungs, in racehorses, part of a mandate contained in its enabling legislation.
The three studies were approved by HISA’s Board of Directors following recommendations issued by its Furosemide Advisory Committee. The costs of the three studies will be $773,500, HISA said.